Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative genomics on SFRP1 orthologs.

Yuriko Katoh1, Masaru Katoh

  • 1M&M Medical BioInformatics, Hongo 113-0033, Japan.

International Journal of Oncology
|August 4, 2005
PubMed
Summary

The rat Sfrp1 gene, a key WNT signaling modulator, was identified and characterized. This study provides the first comparative analysis of Sfrp1 orthologs, revealing conserved regulatory elements and high sequence identity with other species.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-drug conjugates targeting the cadherin, claudin and nectin families of adhesion molecules.

Frontiers in molecular medicine·2025
Same author

Claudin 1, 4, 6 and 18 isoform 2 as targets for the treatment of cancer (Review).

International journal of molecular medicine·2024
Same author

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Frontiers in molecular medicine·2024
Same author

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin-18 isoform 2 splicing variants in gastric cancer and other solid tumours.

Clinical and translational medicine·2024
Same author

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions.

Nature reviews. Clinical oncology·2024
Same author

Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies.

Scientific reports·2024

Area of Science:

  • Genetics
  • Molecular Biology
  • Bioinformatics

Background:

  • Secreted-type WNT signaling modulators, including SFRP1, play critical roles in cellular processes.
  • SFRP1 functions as a tumor suppressor gene, frequently inactivated in various cancers.
  • Understanding Sfrp1 orthologs is crucial for cancer research and therapeutic development.

Purpose of the Study:

  • To identify and characterize the rat Sfrp1 gene.
  • To perform comparative integromics analyses of Sfrp1 orthologs across species.
  • To investigate the conserved regulatory elements in Sfrp1 promoters.

Main Methods:

  • Bioinformatic analysis of genomic and EST sequences to identify and assemble the rat Sfrp1 gene.
  • Amino acid sequence analysis to determine protein domains and conserved residues.
  • Comparative sequence analysis to assess homology with Sfrp1 orthologs from other species.
  • Promoter analysis using the Match program to identify conserved transcription factor binding sites.

Main Results:

  • The rat Sfrp1 gene was identified and its complete coding sequence determined.
  • Rat Sfrp1 (314 aa) comprises a signal peptide, Frizzled domain, and Netrin domain.
  • High amino acid identity was observed between rat Sfrp1 and orthologs in mouse (98.7%) and human (95.2%).
  • Conserved AP1, COMP1, and ETS1 binding sites were identified in the promoter regions of human SFRP1 and rat Sfrp1.

Conclusions:

  • This study provides the first comprehensive characterization of the rat Sfrp1 gene and its comparative analysis with orthologs.
  • The identified conserved features suggest functional importance of Sfrp1 across species.
  • Findings contribute to understanding WNT signaling pathway regulation and potential therapeutic targets in cancer.

Related Experiment Videos